chrisvoncsefalvay/vaers-outcomes huggingface dataset:
received only diluent component of Shingrix, without the powder; received only diluent component of Shingrix, without the powder; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 69-year-old female patient who received Herpes zoster (Shingrix) (batch number NJ75B, expiry date 21-AUG-2024) for prophylaxis.   On 03-OCT-2023, the patient received Shingrix. On 03-OCT-2023, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: received only diluent component of Shingrix, without the powder) and inappropriate dose of vaccine administered (Verbatim: received only diluent component of Shingrix, without the powder).  The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 3-Oct-2023 The case was received from the medical assistant. The reporter consented to follow-up via email. The patient only received diluent component of shingrix without powder, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
pt was given shots @ 3PM on 27APR94; pt slept from 830PM-530AM which was very unusual; pt recvd  1/2 dropper APAP immed p/vax;
Information has been received from a health professional concerning a 21 year old female who on 14-JAN-2008 was vaccinated intramuscularly with the first dose of Gardasil (655327/1287U).  On 15-JAN-2008 the patient experienced dizziness, nausea, diarrhea and a red, blotchy, itchy rash to her upper torso.  The patient's dizziness, nausea, diarrhea and red, blotchy, itchy rash to her upper torso persisted.  The patient sought unspecified medical attention.  No other information is available at this time.  Follow up AE info (17-JAN-2008):  The representative called to make sure that this AE was reported.  No further information was provided.  Additional information has been requested.
muscle pain; joint pain; headache; dizziness; lymph node swelling under both arms; extreme fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MYALGIA (muscle pain), ARTHRALGIA (joint pain), HEADACHE (headache), DIZZINESS (dizziness) and LYMPHADENOPATHY (lymph node swelling under both arms) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported. No concomitant medication reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced MYALGIA (muscle pain), ARTHRALGIA (joint pain), HEADACHE (headache), DIZZINESS (dizziness), LYMPHADENOPATHY (lymph node swelling under both arms) and FATIGUE (extreme fatigue). At the time of the report, MYALGIA (muscle pain), ARTHRALGIA (joint pain), HEADACHE (headache), DIZZINESS (dizziness), LYMPHADENOPATHY (lymph node swelling under both arms) and FATIGUE (extreme fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Severe pain in upper arm lasting more than 1 week and limited mobility in arm after receiving TDAP shot.
11/09/21 Received booster vaccine.  By evening arm swelled slightly, was itchy, went away in about 5 days.  11/16/21 Felt fatigue, chills, achy body and abdominal cramps.  Took two Naproxen that evening and the following day.  Today fatigue, chills achy body are gone.  However, abdominal pain still present.  I have emailed my HCP today to inform her and seek advice.  Side effects listed online indicate that these symptoms are normal, however, abdominal pain is rare, but listed.
@ 1420, patient received last vaccine (Pfizer), he immediately turned pale and was clammy. Cold compresses were place on his anterior and posterior neck, forehead and chest. He began to regain his color and was speaking that he was feeling better. Patient was reassured by nurse that he was safe and would not be left alone.  His partner stated that the patient had not eaten since the day before, it was now 1420.  Patient ambulated out from clinic @ 1500 without complications.
Extreme aches, extreme loss of focus, extreme cold chills followed by extreme sweating. Headaches have been persistent as well as what feels like a sinus infection on the 3rd day.
Pt received vaccine on 7/30/15. Came back to store on 8/7/15 with red and swollen shoulder/arm. Shoulder was also hot to touch. Red area was quite large (at elbow level).
February 27 Th.  Began  feeling nasally and having nasal drip.   Congestion started the same day. March 2 I started to feel my chest burning and I had to catch my breathe going up the  stairs and taking also took a lot out of me to do.  Still on March 2 around 11 pm I lost my smell and taste.
Headache 1 st day. Around midnight the 1st day joints bones. Ached horribly.  Exhausted. No temp.
Right arm erythematous 24 hours after, warm to touch. No streaking, no welts.
4AUG dragginess to rt side of body; annoyance; had to think about moving my rt arm/leg; hot arm; stiff let - "peg leg" feeling; pt played tennis p/shot was given & also today again;
Approx 1 1/2 hrs post/vax, stomach cramps, nausea, felt like something sticking in heart. Began fever & chills, approx 4 hrs later. No other sympoms, after this.
Information has been received from a physician concerning a patient who was vaccinated with a dose of Gardasil. It was reported that the patient developed a sore throat. At this reporting time the patient's outcome is unknown.  No further information is available.
Pt experienced increased episodes of apnea and bradycardia. Episodes ended at 2:00 am on 3/20/00.
Arm very sore for 2 days. Third day a rash on both arms. Very itchy so I took Benadryl and it subsided. On the third day the chills started around 2:00 in the afternoon. Went to bed with pajamas ,socks ,and a robe in order to keep warm because of the chills. Woke up this morning and the chills were gone and I feel great.
UTI 3/16/2021-3/20/2021. UTI 4/28/2021. Sensitivity to light 3/24/2021 - current. Blurry Vision 3/20/2021 - 3/24/2021. Partial blindness 4/04/2021 - current. Headaches 3/24/2021 - current.   Doctor ruled not a stroke.  Stroke of the eye due to blood clot or plaque build up is the highest suspected cause. No previous incidents of this nature had occured.
Acute pleuro-pericarditis, take naproxen and cochicine, still recovering This was my first dose. Took vaccine on June 2, mild pain in chest on June 3, it got a bit better after a day or two. It came back on Sunday with more pain suddenly. Went for a walk and it felt better for the rest of the day and also the next day. On Wednesday is was bad, more painful than sunday, went to PCP. Thursday was the worst day, hurt to move, can't move in bed and wakes up from pain from moving or rotating in bed. Having chest pain since last week, sharp pain on the left front of chest. Pain worsens when leaning forward. Significant pleuritic pain. Started taking Naproxen and Cochicine and conditions have been much better. Still recovering with very mild pain in the same area now.
Sore arm; tender arm; sore at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), TENDERNESS (tender arm) and INJECTION SITE PAIN (sore at injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included RAMIPRIL from 10-Oct-2019 to an unknown date for Blood pressure, MULTIVITAMINES AND MINERALS from 01-Jun-1999 to an unknown date.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), TENDERNESS (tender arm) and INJECTION SITE PAIN (sore at injection site). On 30-Jan-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, TENDERNESS (tender arm) and INJECTION SITE PAIN (sore at injection site) outcome was unknown. Not Provided          No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: addition information received on 4 MAY 2021 contain information:  Patient Demographic details updated,  product tab updated and event tab updated.
9 days after 1st Moderna vax I developed a rash below injection site, over my bicep area, I used cold compress and rash went away after a couple days.
The Pfizer COVID-19 Vaccine vials were reconstituted with 1.6mL vs. 1.8mL of normal saline.  This resulted in the patient receiving 33mcg of active vaccine component in the 0.3mL dose instead of the EUA labeled 30mcg.  This has been disclosed to the  DOH and the patient.  Patient reports feeling fine, no adverse side effects.  Reporting through VAERS is required by the DOH given the increase in dose administered.
3 weeks after 1st vaccine I ended up in the hospital  with heart attack. This was exactly one year after getting covid.  Exactly 3 weeks after 2nd vaccine I was back in the hospital with pericarditis and acute kidney failure.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 39-year-old male patient received BNT162b2 (BNT162B2), on 27Sep2021 at 09:30 as dose 3 (booster), single (Lot number: 301308A) at the age of 38 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 2, single (Batch/Lot number: unknown) and as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Type 1 diabetes" (unspecified if ongoing); "Type 1 diabetes with gastroparesis" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing); "low HDL" (unspecified if ongoing); "major depression" (unspecified if ongoing); "restless leg syndrome" (unspecified if ongoing). Concomitant medication(s) included: HUMALOG, start date: 20Aug1998, stop date: 20Aug1998; LAMICTAL; LISINOPRIL; BUPROPION HCL XL; ROPINIROLE; ATORVASTATIN, start date: 01May2016, stop date: 27May2022. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.  Anti-viral details: product-COVID 19 Treatment, brand-Paxlovid. Treatment start date-27May2022, Lot number=GA3588, Indication is used for treatment of COVID-19. Adverse event: I have type 1 diabetes and my blood sugars have been regularly jumping to over 400 mg/dL since taking the antiviral medications. This is especially true in the evening (when I believe the amount is probably maximal in my system). These highs have been very resistant to insulin treatment and large fluid intake. I normally don't see numbers this high basically ever. The patient had Known allergies to NKA. Other medical history: Type 1 diabetes with gastroparesis, high blood pressure, low HDL, major depression, and restless leg syndrome. Adverse event experienced on 27May2022 at 11:00 PM, The outcome of event was Recovering with treatment Increased insulin regiment (self-administered).  No follow-up attempts are needed. No further information is expected.
Next day after the second shot 9-18-21 got mild fever, dody aches and heavy pain coming from my lower back. Sunday the 19th of September fever went away but the the heavy pain from my lower back remains. The pain started to go beyond my lower back to lower abdonal area and hips acompanined with fatige. Whitin a week a redness on my face and sort of rash started to developed on my torso as well. Pain start to spread from my neck, arms, back, hips and thighs. Also pain on my skin when it is touched. I visited Walking urgent care and I was prescribed with prednisone for 2 weeks on the 8th of October. The prednisone apparently started to work but once finished with medication the sympots on my skin worsen and body pain, fatige and tireness remains today.
low fever, sore arm, shivers, aches, headache, tiredness  2 days
nausea; tingling on lips; bad taste in mouth; This case was reported by a other health professional via call center representative and described the occurrence of nausea in a 51-year-old male patient who received HAB (Twinrix adult) (batch number 9355D, expiry date 14th March 2022) for prophylaxis.   On 27th August 2019, the patient received the 1st dose of Twinrix adult. On 27th August 2019, 1 hr after receiving Twinrix adult, the patient experienced nausea, tingling lips and dysgeusia. On an unknown date, the outcome of the nausea, tingling lips and dysgeusia were recovered/resolved.   It was unknown if the reporter considered the nausea, tingling lips and dysgeusia to be related to Twinrix adult.  Additional case details were reported as follows: The patient experienced nausea, tingling in lips, and bad taste in mouth. The events were resolved. The reporter consented to follow up. This is 2 of the 3 linked cases reported by the same reporter.
retine detachment on both eyes; cataracts on both eyes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old male patient received bnt162b2 (BNT162B2), on 06May2021 at 12:00 as dose 2, single (Lot number: EW0168) at the age of 49 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: bnt162b2 (DOSE 1, SINGLE, Batch/Lot No: ER8735, Location of injection: Arm Right, At 12:00 AM), administration date: 15Apr2021, for COVID-19 immunisation. The following information was reported: CATARACT (hospitalization, disability) with onset 25Feb2023 at 22:00, outcome "recovered with sequelae", described as "cataracts on both eyes"; RETINAL DETACHMENT (hospitalization, disability) with onset 25Feb2023 at 22:00, outcome "recovered with sequelae", described as "retine detachment on both eyes". The patient was hospitalized for retinal detachment, cataract (hospitalization duration: 2 day(s)). The events "retine detachment on both eyes" and "cataracts on both eyes" required emergency room visit. Therapeutic measures were taken as a result of retinal detachment, cataract. Clinical course: Patient did not had covid before the vaccination, not tested positive for covid post vaccination. Patient did not had known allergies, no medical history. No other vaccine was received in four weeks. No other medications were received in two weeks. Patient stated he had retine detachment on both eyes, one first and 15 days later the other eye, 5 months at home recovering and then had cataracts on both eyes. He stated that he must go back to the hospital to make, possibly, another surgery in both eyes.
I went in because I am immune compromised to get a 3rd moderna vaccine recommended by my doctor. I filled out a form online stated I had to moderna shots, I filled a form and hand delivered it that started I?d had 2 moderna vaccines. I also gave them my vaccine card with moderna written on it. They proceeded and gave me a Pfizer vaccine.
the patient tested for COVID-19  on 6/21/2021  and the result came positive , two days before testing the patient have SOB
After my second dose I received my menstrual cycle twice. I had a normal period cycle on June 20th as expected. Then 12 days later I had a second period with heavy flow and spotting along with stomach cramps.
@ 10:55am after Varicell administration pt muscle stiffen pale 02 - 91 L 23 101/45 syncope episode. Pt received 02 = 100% spc 2 BP up 109/62 P47. Pt alert and oriented x3 @ 10:57 @ 11:10 113/74 P98.
Information had been received on 12-SEP-2017 from a lawyer regarding a case in litigation. It was alleged in litigation that a female patient (age unknown) was inoculated with ZOSTAVAX on or about 22-JAN-2013 at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles (dosage and lot#/expiration not reported). The vaccine did not prevent shingles as intended but rather caused the patient to contract a persistent and chronic strain of herpes zoster. On or about 06-SEP-2016, patient was treated for herpetic neuritis and prescribed valacyclovir by a physician. On or about 16-NOV-2016, patient was treated by physician for a blistering vesicular outbreak that was diagnosed as severe herpes zoster, or shingles accompanied by post-herpetic neuritis. Patient has been prescribed VALTREX, LYRICA, gabapentin, NEURONTIN and lidocaine cream for management of her painful symptoms and herpetic complications. As a direct and proximate result of these malfunctions, patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Additional information has been requested.
Information has been received from a nurse practitioner concerning a female who on 02-FEB-2010 was vaccinated with a dose of GARDASIL. On an unspecified date the patient developed rash, on her neck, arm, and back. The patient was treated with BENADRYL but the rash worsened and the patient went to an emergency room. At the time of this report the patient's outcome was unknown. Additional information has been requested.
Three days after my first Pfizer Covid shot in late March 2021, I began to experience extreme insomnia, which I have never had before. I was 64 at the time and never experienced anything like this. It went on for 2 months, before I contacted my doctor. I was given several meds that did not work and it took me months to get into a sleep doctor.  Finally in late August, after 6 months of hell, with the right sleep medication, my insomnia has gotten better. But I need to take a sleep pill.  I have read about it online and it was confirmed by one sleep doctor that he had heard, but not read about this adverse event.
Immunocompromised; patient is skinny/underweight; having a multiple sclerosis relapse/Multiple Sclerosis flared up after she got the vaccine; double vision that is intermittent and unilateral; had a funny feeling around the lips, tongue, and on the left side of her face; This is a spontaneous combined report from a contactable consumer (patient) via Pfizer. A 51-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EN6199) (51 year at the time of vaccination) via an unspecified route of administration in arm left on 15Apr2021 at 10:30 as single dose for COVID-19 immunization. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Medical history included multiple sclerosis from 2000 and ongoing. The patient's concomitant medications were not reported. On 15Apr2021, after the first dose the patient started experiencing double vision and had funny feeling in her lip, tongue and left side of the face (started prior taking the vaccine). The patient said she might be relapsing from multiple sclerosis. The patient was confused whether she should take the second dose of the vaccine. The patient also received IV methylprednisolone (3gm) (to be administered over 2 hours for three days) and taking prednisone for her double vision which comes and goes. Patient stated she had been immunosuppressed due to being on prednisone for 7days. The patient went to the health care professional and the health care professional gave her a steroid and patient stated the steroid was not responding to the double vision. The patient reported that she does not remember having any issues with her eyes subsequent to taking the vaccine which could be coincidental or nothing to do with the vaccine, but she then developed double vision which was getting worse. The patient also reported that she was skinny and underweight. The patient took 3 grams of Solumedrol IV and it did not help her. Therapeutic measures were taken in response to the events and the patient also had to visit emergency room. The outcome of the event's multiple sclerosis relapse, double vision, immunocompromised and skinny/underweight was unknown while for the event funny feeling around the lips, tongue, and on the left side of her face it was reported as not recovered.   Information on Lot/Batch number was available. Additional information has been requested.
Patient came in to get the second dose of Moderna vaccine. That dose is 0.5ml, in error the patient was given the Moderna Booster dose which is 0.25ml. According to CDC Administration Errors Revaccination Guidance patient must receive a repeat dose. Patient will be given repeat dose of 0.5ml.
Mild nausea; This is a spontaneous report from a contactable consumer (patient). A 73-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration on 28Jan2021 18:30 at single dose (right arm) for covid-19 immunization. Medical history included allergies, asthma and Clostridium difficile (c.dif). Patient had allergies to medications, food or other products. The patient was not pregnant. Concomitant medication included rosuvastatin within 2 weeks of vaccination. The patient received other vaccine within 4 weeks prior to Covid vaccine included 1 dose of pneumonia vaccine on 07Jan2021 at a clinic. On 28Jan2021 18:30, the patient experienced mild nausea. Treatment was not received for the event. Prior to vaccination, patient was not diagnosed with COVID-19 and since the vaccination, patient has not patient been tested for covid-19. Outcome of event was recovered on an unspecified date.  Information on the lot/batch number has been requested.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 14-NOV-2015 at time- 21:42, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 3.2 and 2.6 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.